FDA: Ameridose issues voluntary recall of all products

November 2, 2012
FDA: ameridose issues voluntary recall of all products
Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release issued by the U.S. Food and Drug Administration.

(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release issued by the U.S. Food and Drug Administration.

As yet, no patients have been reported to have experienced infections or other complications in association with Ameridose products. The recall was prompted out of concern that sterility assurance for products made and distributed by the facility is lacking. This concern was raised by the preliminary findings of an FDA investigation of the manufacturer's facility as part of an ongoing investigation into the fungal linked with Ameridose's sister company, the Compounding Center of Framingham, Mass.

Acknowledging that the recall stems from an abundance of caution rather than an actual adverse event, the FDA is not at this time recommending that physicians follow up with patients who have received Ameridose products, only that they stop using these products and return them. Hospitals, clinics, and other customers with Ameridose products can call the company at 888-820-0622 for guidance on returning the products.

"The FDA's top priority is to ensure that drugs are safe for the American public," Margaret A. Hamburg, M.D., FDA Commissioner, said in a statement.

Explore further: Charlie's-brand cantaloupe recalled

More information: More Information

Related Stories

Charlie's-brand cantaloupe recalled

March 24, 2008

The U.S. Food and Drug Administration announced the recall of Charlie's-brand cut cantaloupe products due to possible contamination.

Some Total Body-brand products recalled

March 31, 2008

The U.S. Food and Drug Administration announced the recall of certain flavors of Total Body Formula and Total Body Mega Formula due to safety issues.

US pharmacy linked to outbreak issues wide recall

October 7, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

2nd firm agrees to temporary shutdown in outbreak

October 10, 2012

(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

Suit: Firm provided tainted meds in 2002, man died

October 11, 2012

The compounding pharmacy suspected in a deadly meningitis outbreak settled a lawsuit alleging it produced a tainted shot that caused a man's death in 2004, while a pharmaceutical firm with common owners was accused this summer ...

Tainted drug death toll rises to 14 in US

October 11, 2012

The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.

Recommended for you

Treatment options for opioid addiction are expanding

August 10, 2016

In the past two decades, the devastation associated with opioid addiction has escaped the relative confines of the inner city and extended to suburban and rural America. Due in large part to the proliferation of prescription ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.